Get started
Work

CD8 Presence and Dynamics in Glofitamab-Treated Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Using the CD8-Specific PET Tracer 89Zr-Crefmirlimab Berdoxam

Year: 2022
Type: article
Source: Blood
DOI: 10.1182/blood-2022-158154
Authors: Martin Hutchings, Annika Loft, Wendy Osborne, George Petrides, Fritz Offner, Ciel De Vriendt, Giuseppe Gritti, Roberto Boni, William Townsend, Irfan Kayani, Ian Wilson, Yanjie Wang, Maria Jadhav, Cristina Santini, Claire Kelly, Martin Kornacker, Jean J.L. Tessier, Ann-Marie E Bröske, Angelika Lahr, Axel Boehnke, Christoph M. Griessinger
Institutions: Rigshospitalet, Newcastle upon Tyne Hospitals NHS Foundation Trust, Ghent University Hospital, Ospedale Papa Giovanni XXIII, Cancer Research UK, University College London, ImaginAb (United States), Roche (China), Roche (Switzerland), Roche (United Kingdom), Roche Pharma AG (Germany)
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4310106186
FWCI: 0.141
Cites:
Cited by: 1
Related to: 10